Richard E Kast

Author PubWeight™ 2.56^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Disulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition.	Oncoscience	2013	0.94
2	CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.	Oncotarget	2014	0.89
3	Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen.	Onco Targets Ther	2016	0.77
4	The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.	Breast Cancer (Dove Med Press)	2017	0.75
5	Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.	Oncotarget	2017	0.75
6	Anti-glioma Activity of Dapsone and Its Enhancement by Synthetic Chemical Modification.	Neurochem Res	2017	0.75
7	Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.	Oncotarget	2017	0.75